Literature DB >> 6402590

The long-term effects of treating rheumatoid arthritis.

D L Scott, B L Coulton, J H Chapman, P A Bacon, A J Popert.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6402590      PMCID: PMC5370976     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


× No keyword cloud information.
  43 in total

1.  COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

Authors:  J J DUTHIE; P E BROWN; L H TRUELOVE; F D BARAGAR; A J LAWRIE
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

2.  Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis.

Authors:  E B HAMILTON; J T SCOTT
Journal:  Arthritis Rheum       Date:  1962-10

3.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

4.  GOLD therapy in rheumatoid arthritis. Report of a multicentre control trial.

Authors: 
Journal:  Ann Rheum Dis       Date:  1960-06       Impact factor: 19.103

5.  Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year.

Authors:  A FREEDMAN; V L STEINBERG
Journal:  Ann Rheum Dis       Date:  1960-09       Impact factor: 19.103

6.  Chloroquine diphosphate in rheumatoid arthritis. A controlled trial.

Authors:  A J POPERT; K A MEIJERS; J SHARP; F BIER
Journal:  Ann Rheum Dis       Date:  1961-03       Impact factor: 19.103

7.  Course and prognosis in rheumatoid arthritis.

Authors:  J J DUTHIE; P E BROWN; J D KNOX; M THOMPSON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

8.  A COMPARISON of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis; a second report by the Joint Committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, A.C.T.H., and other therapeutic measures in chronic rheumatic diseases.

Authors: 
Journal:  Br Med J       Date:  1955-09-17

9.  Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis.

Authors:  B McConkey; P Davies; R A Crockson; A P Crockson; M Butler; T J Constable; R S Amos
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

10.  A COMPARISON of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis; a report by the Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, A.C.T.H., and Other Therapeutic Measures in Chronic Rheumatic Diseases.

Authors: 
Journal:  Br Med J       Date:  1954-05-29
View more
  14 in total

Review 1.  Combination therapy for autoimmune diseases: the rheumatoid arthritis model.

Authors:  N Fathy; D E Furst
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis.

Authors:  L E Hart; P Tugwell
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

3.  Clinical value of ELISA assays for IgM and IgG rheumatoid factors.

Authors:  R Stone; J S Coppock; P T Dawes; P A Bacon; D L Scott
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

Review 4.  Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs.

Authors:  D L Scott; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

Review 5.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

Review 6.  Assessing the progression of joint damage in rheumatoid arthritis.

Authors:  D L Scott; M Farr
Journal:  Drugs       Date:  1986       Impact factor: 9.546

7.  Pharmacological studies of antigen-induced arthritis in BALB/c mice. II. The effects of second-line antirheumatic drugs and cytotoxic agents on the histopathological changes.

Authors:  I M Hunneyball; M J Crossley; M Spowage
Journal:  Agents Actions       Date:  1986-06

8.  Referral of chronic arthritics.

Authors:  M A Chamberlain
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-04

9.  Rheumatoid inflammation and joint destruction: cause and effect or parallel phenomena?

Authors:  J D Williams; D L Scott; F B DeBrito; D A Willoughby; E C Huskisson
Journal:  Agents Actions       Date:  1986-08

10.  Outcome in patients hospitalised for psoriatic arthritis.

Authors:  B L Coulton; K Thomson; D P Symmons; A J Popert
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.